Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (114)
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
37,000
Price
$3.67
Total Value
$135.62K
Shares Held After
3,133,000
% of Holdings
1.2%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
5,000
Price
$2.76
Total Value
$13.80K
Shares Held After
662,000
% of Holdings
0.8%
RELMADA THERAPEUTICS, INC. (RLMD)
TRAVERSA SERGIO — Director
Shares
100,000
Price
$4.10
Total Value
$410.00K
Shares Held After
1,500,000
% of Holdings
6.7%
RELMADA THERAPEUTICS, INC. (RLMD)
Shenouda Maged — Chief Financial Officer
Shares
79,800
Price
$4.25
Total Value
$339.15K
Shares Held After
1,000,000
% of Holdings
8.0%
Metagenomi Therapeutics, Inc. (MGX)
Reid Laurence — Director
Shares
117
Price
$1.18
Total Value
$138.06
Shares Held After
20,000
% of Holdings
0.6%
Metagenomi Therapeutics, Inc. (MGX)
Reid Laurence — Director
Shares
19,883
Price
$1.17
Total Value
$23.26K
Shares Held After
19,883
% of Holdings
100.0%
Tyra Biosciences, Inc. (TYRA)
Verjee Rehan — Director
Shares
972
Price
$20.58
Total Value
$20.00K
Shares Held After
972
% of Holdings
100.0%
RELMADA THERAPEUTICS, INC. (RLMD)
TRAVERSA SERGIO — Director
Shares
100,000
Price
$4.18
Total Value
$418.00K
Shares Held After
1,400,000
% of Holdings
7.1%
RELMADA THERAPEUTICS, INC. (RLMD)
Shenouda Maged — Chief Financial Officer
Shares
120,200
Price
$4.20
Total Value
$504.84K
Shares Held After
920,200
% of Holdings
13.1%
YD Bio Ltd (YDES)
Shen Ethan PhD — Director
Shares
3,100
Price
$3.93
Total Value
$12.18K
Shares Held After
11,245,631
% of Holdings
0.0%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
5,836
Price
$2.09
Total Value
$12.20K
Shares Held After
2,775,229
% of Holdings
0.2%
Grace Therapeutics, Inc. (GRCE)
Kohli Prashant — Director
Shares
100,000
Price
$2.14
Total Value
$214.00K
Shares Held After
121,357
% of Holdings
82.4%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
3,097
Price
$68.70
Total Value
$212.78K
Shares Held After
536,876
% of Holdings
0.6%
CYBIN INC. (CYBN)
So Eric H. L. — Director
Shares
100,000
Price
$12.39
Total Value
$1.24M
Shares Held After
4,465,014
% of Holdings
2.2%
CYBIN INC. (CYBN)
Glavine Paul — Chief Growth Officer
Shares
100,000
Price
$12.47
Total Value
$1.25M
Shares Held After
4,271,252
% of Holdings
2.3%
CYBIN INC. (CYBN)
Glavine Paul — Chief Growth Officer
Shares
100,000
Price
$12.47
Total Value
$1.25M
Shares Held After
4,271,252
% of Holdings
2.3%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
9,393
Price
$2.10
Total Value
$19.70K
Shares Held After
2,769,393
% of Holdings
0.3%
ALUMIS INC. (ALMS)
AKKARAJU SRINIVAS — Director
Shares
273,290
Price
$10.63
Total Value
$2.90M
Shares Held After
2,298,783
% of Holdings
11.9%
ALUMIS INC. (ALMS)
AKKARAJU SRINIVAS — Director
Shares
273,291
Price
$10.63
Total Value
$2.90M
Shares Held After
4,937,026
% of Holdings
5.5%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
471
Price
$69.37
Total Value
$32.67K
Shares Held After
533,779
% of Holdings
0.1%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
3,390
Price
$68.74
Total Value
$233.03K
Shares Held After
533,308
% of Holdings
0.6%
Inhibrx Biosciences, Inc. (INBX)
Kayyem Jon Faiz — Director
Shares
5,000
Price
$113.52
Total Value
$567.58K
Shares Held After
424,360
% of Holdings
1.2%
Inhibrx Biosciences, Inc. (INBX)
FORSYTH DOUGLAS — Director
Shares
2,500
Price
$114.65
Total Value
$286.62K
Shares Held After
227,064
% of Holdings
1.1%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
9,681
Price
$112.28
Total Value
$1.09M
Shares Held After
730,548
% of Holdings
1.3%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
1,219
Price
$111.88
Total Value
$136.38K
Shares Held After
720,867
% of Holdings
0.2%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
500
Price
$108.23
Total Value
$54.12K
Shares Held After
719,648
% of Holdings
0.1%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
1,100
Price
$107.12
Total Value
$117.84K
Shares Held After
719,148
% of Holdings
0.2%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
6,605
Price
$100.64
Total Value
$664.72K
Shares Held After
718,048
% of Holdings
0.9%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
5,895
Price
$99.29
Total Value
$585.34K
Shares Held After
711,443
% of Holdings
0.8%
CYBIN INC. (CYBN)
So Eric H. L. — Director
Shares
100,000
Price
$12.09
Total Value
$1.21M
Shares Held After
4,365,014
% of Holdings
2.3%
ALUMIS INC. (ALMS)
AKKARAJU SRINIVAS — Director
Shares
220,070
Price
$11.17
Total Value
$2.46M
Shares Held After
2,073,558
% of Holdings
10.6%
ALUMIS INC. (ALMS)
AKKARAJU SRINIVAS — Director
Shares
220,070
Price
$11.17
Total Value
$2.46M
Shares Held After
4,711,801
% of Holdings
4.7%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
2,100
Price
$68.98
Total Value
$144.86K
Shares Held After
529,918
% of Holdings
0.4%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
918
Price
$69.52
Total Value
$63.82K
Shares Held After
527,818
% of Holdings
0.2%
YD Bio Ltd (YDES)
Shen Ethan PhD — Director
Shares
18,378
Price
$3.67
Total Value
$67.45K
Shares Held After
11,242,531
% of Holdings
0.2%
Atara Biotherapeutics, Inc. (ATRA)
Cherry Brian N — Director
Shares
104,166
Price
$9.60
Total Value
$999.99K
Shares Held After
166,486
% of Holdings
62.6%
CYBIN INC. (CYBN)
Glavine Paul — Chief Growth Officer
Shares
100,000
Price
$11.78
Total Value
$1.18M
Shares Held After
4,171,252
% of Holdings
2.4%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
900,000
Price
$1.78
Total Value
$1.60M
Shares Held After
6,524,151
% of Holdings
13.8%
Orchestra BioMed Holdings, Inc. (OBIO)
Hochman David P — Director
Shares
10,000
Price
$4.79
Total Value
$47.90K
Shares Held After
1,070,746
% of Holdings
0.9%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
800
Price
$1.09
Total Value
$872.00
Shares Held After
381,985
% of Holdings
0.2%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
27,000
Price
$9.47
Total Value
$255.74K
Shares Held After
827,000
% of Holdings
3.3%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
900
Price
$68.95
Total Value
$62.05K
Shares Held After
526,900
% of Holdings
0.2%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
187,704
Price
$1.80
Total Value
$337.59K
Shares Held After
5,624,151
% of Holdings
3.3%
CYBIN INC. (CYBN)
So Eric H. L. — Director
Shares
95,000
Price
$11.80
Total Value
$1.12M
Shares Held After
4,265,014
% of Holdings
2.2%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
783
Price
$69.52
Total Value
$54.43K
Shares Held After
526,000
% of Holdings
0.1%
AN2 Therapeutics, Inc. (ANTX)
FitzPatrick Margaret M — Director
Shares
2,098
Price
$5.53
Total Value
$11.60K
Shares Held After
10,708
% of Holdings
19.6%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
179,058
Price
$1.80
Total Value
$321.57K
Shares Held After
5,436,447
% of Holdings
3.3%
MediWound Ltd. (MDWD)
Rubinstein Samuel — Director
Shares
525
Price
$12.62
Total Value
$6.63K
Shares Held After
525
% of Holdings
100.0%
CYBIN INC. (CYBN)
Glavine Paul — Chief Growth Officer
Shares
90,000
Price
$11.59
Total Value
$1.04M
Shares Held After
4,071,252
% of Holdings
2.2%
ALTERITY THERAPEUTICS LTD (ATHE)
Marks Peter Ashley — Director
Shares
47,620
Price
$0.50
Total Value
$23.81K
Shares Held After
191,340
% of Holdings
24.9%
Showing 1–50 of 114 transactions (page 1 of 3)